v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended
Jan. 31, 2026
Feb. 01, 2025
Cash flows from operating activities:    
Net income $ 1,628,326 $ 1,980,422
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 67,160 42,576
Undistributed earnings in joint venture - Majestic 21 (26,191) (25,805)
Gain on disposal of property, plant and equipment (1,000) 0
(Increase) decrease in fair market value of equity investment (39,866) 2,916
Stock-based compensation 60,138 40,254
Decrease (increase) in:    
Accounts receivable - trade 652,432 1,013,502
Inventories (534,546) 765,079
Prepaid expenses and other current assets 74,479 37,509
Interest receivable (133,640) (146,066)
(Decrease) increase in:    
Accounts payable 100,745 14,974
Accrued compensation (354,562) (176,179)
Accrued expenses and other current liabilities (187,423) (322,625)
Income taxes payable (132,270) (76,210)
Customer deposits 656,186 (732,481)
Net cash provided by operating activities 1,829,968 2,417,866
Cash flows from investing activities:    
Purchase of property, plant and equipment (435) (117,198)
Purchase of certificates of deposit (3,500,000) (1,500,000)
Proceeds from certificates of deposit 2,500,000 1,920,000
Proceeds disposal of property, plant and equipment 1,000 0
Collections on interest receivable 58,419 99,644
Collections on mortgage notes receivable (154) 476
Increase in cash surrender value of life insurance (66,000) (51,000)
Net cash (used in) provided by investing activities (1,007,170) 351,922
Cash flows from financing activities:    
Purchase of treasury stock (2,970,000) 0
Net cash (used in) financing activities (2,970,000) 0
(Decrease) Increase in cash and cash equivalents (2,147,202) 2,769,788
Cash and cash equivalents at beginning of period 13,230,504 13,521,296
Cash and cash equivalents at end of period 11,083,302 16,291,084
Supplemental financing activity:    
Income taxes paid 685,000 745,000
Interest paid $ 0 $ 0